EnglishGerman Overview In this section you can find all materials related to our financial reporting Latest Annual Report (20-F) March 30, 2022 20-F 0001776985-22-000019.pdf Latest Annual Report (German) BioNTech Geschaeftsbericht 2019 Open Latest Quarterly Report Show all 2022 Q1 Q1 2022 Press Release Q1 2022 Presentation 2.1 MB Q1 2022 Webcast Recording Q1 2022 Financial Report 9.3 MB Latest SEC Filings Filing date Description Form View June 30, 2022 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K View HTML 0001776985-22-000042.pdf 0001776985-22-000042.rtf 0001776985-22-000042.xls June 30, 2022 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K View HTML 0001776985-22-000041.pdf 0001776985-22-000041.rtf 0001776985-22-000041.xls June 27, 2022 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K View HTML 0001776985-22-000040.pdf 0001776985-22-000040.rtf 0001776985-22-000040.xls
Overview In this section you can find all materials related to our financial reporting Latest Annual Report (20-F) March 30, 2022 20-F 0001776985-22-000019.pdf Latest Annual Report (German) BioNTech Geschaeftsbericht 2019 Open Latest Quarterly Report Show all 2022 Q1 Q1 2022 Press Release Q1 2022 Presentation 2.1 MB Q1 2022 Webcast Recording Q1 2022 Financial Report 9.3 MB Latest SEC Filings Filing date Description Form View June 30, 2022 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K View HTML 0001776985-22-000042.pdf 0001776985-22-000042.rtf 0001776985-22-000042.xls June 30, 2022 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K View HTML 0001776985-22-000041.pdf 0001776985-22-000041.rtf 0001776985-22-000041.xls June 27, 2022 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K View HTML 0001776985-22-000040.pdf 0001776985-22-000040.rtf 0001776985-22-000040.xls